Literature DB >> 23726177

Trends in the prevalence, awareness, treatment and control of high low density lipoprotein-cholesterol among United States adults from 1999-2000 through 2009-2010.

Paul Muntner1, Emily B Levitan, Todd M Brown, Pradeep Sharma, Hong Zhao, Vera Bittner, Stephen Glasser, Meredith Kilgore, Huifeng Yun, J Michael Woolley, Michael E Farkouh, Robert S Rosenson.   

Abstract

Marked increases in the awareness, treatment, and control of high low-density lipoprotein (LDL) cholesterol occurred among United States (US) adults from 1988-1994 to 1999-2004. An update to the Third Adult Treatment Panel guidelines was published in 2004, and it is unknown if these improvements have continued since the publication of these revised treatment recommendations. The aim of this study was to determine trends in the awareness, treatment, and control of high LDL cholesterol among US adults from 1999-2000 to 2009-2010 using nationally representative samples of US adults aged ≥20 years from 6 consecutive National Health and Nutrition Examination Surveys (NHANES) in 1999-2000 (n = 1,659), 2001-2002 (n = 1,897), 2003-2004 (n = 1,698), 2005-2006 (n = 1,692), 2007-2008 (n = 2,044), and 2009-2010 (n = 2,318). LDL cholesterol was measured after an overnight fast, and high LDL cholesterol and controlled LDL cholesterol were defined using the 2004 updated Third Adult Treatment Panel guidelines. Awareness and treatment of high cholesterol were defined using self-report. Among US adults, the prevalence of high LDL cholesterol did not change from 1999-2000 (37.2%) to 2009-2010 (37.8%). Awareness of high LDL cholesterol increased from 48.9% in 1999-2000 to 62.8% in 2003-2004 but did not increase further through 2009-2010 (61.5%). Among those aware of having high LDL cholesterol, treatment increased from 41.3% in 1999-2000 to 72.6% in 2007-2008 and was 70.0% in 2009-2010. Among US adults receiving treatment for high LDL cholesterol, the percentage with controlled LDL cholesterol increased from 45.0% in 1999-2000 to 65.3% in 2005-2006 and had decreased slightly by 2009-2010 (63.6%). In conclusion, high LDL cholesterol remains common among US adults. Additional efforts are needed to prevent high LDL cholesterol and increase the awareness, treatment, and control of high LDL cholesterol among US adults.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23726177      PMCID: PMC3769104          DOI: 10.1016/j.amjcard.2013.04.041

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

1.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

2.  Assessment of antihyperlipidemic therapy in US patients with coronary heart disease.

Authors:  Ashley Moser; Larry W Segars
Journal:  J Am Osteopath Assoc       Date:  2010-06

3.  Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate.

Authors:  Josef Coresh; Brad C Astor; Geraldine McQuillan; John Kusek; Tom Greene; Frederick Van Lente; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2002-05       Impact factor: 8.860

Review 4.  Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

Authors:  Scott M Grundy; James I Cleeman; C Noel Bairey Merz; H Bryan Brewer; Luther T Clark; Donald B Hunninghake; Richard C Pasternak; Sidney C Smith; Neil J Stone
Journal:  Circulation       Date:  2004-07-13       Impact factor: 29.690

5.  Trends in lipids and lipoproteins in US adults, 1988-2010.

Authors:  Margaret D Carroll; Brian K Kit; David A Lacher; Susan T Shero; Michael E Mussolino
Journal:  JAMA       Date:  2012-10-17       Impact factor: 56.272

6.  Trends in ATP-III-defined high blood cholesterol prevalence, awareness, treatment and control among U.S. adults.

Authors:  Amanda D Hyre; Paul Muntner; Andy Menke; Paolo Raggi; Jiang He
Journal:  Ann Epidemiol       Date:  2007-03-28       Impact factor: 3.797

7.  Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program guidelines.

Authors:  Devin Mann; Kristi Reynolds; Donald Smith; Paul Muntner
Journal:  Ann Pharmacother       Date:  2008-07-22       Impact factor: 3.154

8.  Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity.

Authors:  K G M M Alberti; Robert H Eckel; Scott M Grundy; Paul Z Zimmet; James I Cleeman; Karen A Donato; Jean-Charles Fruchart; W Philip T James; Catherine M Loria; Sidney C Smith
Journal:  Circulation       Date:  2009-10-05       Impact factor: 29.690

  8 in total
  29 in total

1.  Implementation of Cardiovascular Disease Prevention Guidelines in Clinical Practice-Can We Do Better?

Authors:  Kornelia Kotseva
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-12

2.  Validation of the atherosclerotic cardiovascular disease Pooled Cohort risk equations.

Authors:  Paul Muntner; Lisandro D Colantonio; Mary Cushman; David C Goff; George Howard; Virginia J Howard; Brett Kissela; Emily B Levitan; Donald M Lloyd-Jones; Monika M Safford
Journal:  JAMA       Date:  2014-04-09       Impact factor: 56.272

3.  Complementary Cholesterol-Lowering Response of a Phytosterol/α-Lipoic Acid Combination in Obese Zucker Rats.

Authors:  Todd C Rideout; Bradley Carrier; Shin Wen; Amy Raslawsky; Richard W Browne; Scott V Harding
Journal:  J Diet Suppl       Date:  2015-02-09

Review 4.  Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner
Journal:  Circulation       Date:  2017-01-25       Impact factor: 29.690

5.  Statin underuse and low prevalence of LDL-C control among U.S. adults at high risk of coronary heart disease.

Authors:  Christopher M Gamboa; Monika M Safford; Emily B Levitan; Devin M Mann; Huifeng Yun; Stephen P Glasser; J Michael Woolley; Robert Rosenson; Michael Farkouh; Paul Muntner
Journal:  Am J Med Sci       Date:  2014-08       Impact factor: 2.378

6.  A defined, plant-based diet utilized in an outpatient cardiovascular clinic effectively treats hypercholesterolemia and hypertension and reduces medications.

Authors:  Rami S Najjar; Carolyn E Moore; Baxter D Montgomery
Journal:  Clin Cardiol       Date:  2018-03-25       Impact factor: 2.882

7.  Awareness of Cardiovascular Risk Factors in U.S. Young Adults Aged 18-39 Years.

Authors:  Emily M Bucholz; Holly C Gooding; Sarah D de Ferranti
Journal:  Am J Prev Med       Date:  2018-02-09       Impact factor: 5.043

8.  Black-White Differences in 20-year Trends in Cardiovascular Risk in the United States, 1990-2010.

Authors:  Uchechi A Mitchell; Jennifer A Ailshire; Jung Ki Kim; Eileen M Crimmins
Journal:  Ethn Dis       Date:  2019-10-17       Impact factor: 1.847

9.  Association of Serum Lipids and Coronary Heart Disease in Contemporary Observational Studies.

Authors:  Lisandro D Colantonio; Vera Bittner; Kristi Reynolds; Emily B Levitan; Robert S Rosenson; Maciej Banach; Shia T Kent; Stephen F Derose; Hui Zhou; Monika M Safford; Paul Muntner
Journal:  Circulation       Date:  2015-12-09       Impact factor: 29.690

10.  Comparative impact of implementing the 2013 or 2014 cholesterol guideline on vascular events in a quality improvement network.

Authors:  Brent M Egan; Susan E Sutherland; William F Childers; Ruthanne M Dahlheimer; George A Helmrich; Daryl A Lapeyrolerie; Nancy Markle; Dennis W Murphy; Locke Simmons; Robert A Davis; Peter Tilkemeier; Angelo Sinopoli
Journal:  Ther Adv Cardiovasc Dis       Date:  2016-01-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.